Analysis assesses COVID-19 vaccine effects on UK stock returns, suggesting economic recovery links.
This study sheds light on the interaction between COVID‐19 vaccinations and economic recovery from the pandemic crisis. Using London Stock Exchange data (Jan 10, 2021, to Feb 24, 2022) and fixed‐effects regression methods, this study assesses COVID‐19 vaccine effects on UK stock returns. Initial protocol doses have a strong positive impact on returns, while boosters have a modest positive impact. A logarithmic unit increase in daily vaccine doses corresponds to a 0.07 percentage point increase in daily stock return. Stringent closure policies strengthen the positive influence of the vaccine on returns. Sector‐wise, healthcare responds most positively, while basic resources and food/beverage industries show positive but muted effects.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: